Galantamine Hydrobromide
These highlights do not include all the information needed to use GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES. GALANTAMINE HYDROBROMIDE extended-release capsules, for oral use Initial U.S. Approval: 2001
d1697161-ebe8-42b0-83e7-c9de4412546c
HUMAN PRESCRIPTION DRUG LABEL
Oct 26, 2023
Sun Pharmaceutical Industries, Inc.
DUNS: 146974886
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Galantamine Hydrobromide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Galantamine Hydrobromide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
Galantamine Hydrobromide
Product Details
FDA regulatory identification and product classification information